{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T02:53:40Z","timestamp":1789268020144,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K06928"],"award-info":[{"award-number":["22K06928"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K07483"],"award-info":[{"award-number":["23K07483"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K10154"],"award-info":[{"award-number":["22K10154"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K25180"],"award-info":[{"award-number":["23K25180"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jphs.2025.12.004","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:28:04Z","timestamp":1765931284000},"page":"132-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Src-dependent modulation of IFN\u03b3-induced PD-L1 expression in human breast cancer cell lines"],"prefix":"10.1016","volume":"160","author":[{"given":"Chihiro","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akane","family":"Nagasako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wakana","family":"Fukae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1812-5720","authenticated-orcid":false,"given":"Masanari","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jphs.2025.12.004_bib1","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.jphs.2025.12.004_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41523-022-00468-0","article-title":"Triple negative breast cancer: pitfalls and progress","volume":"8","author":"Zagami","year":"2022","journal-title":"npj Breast Cancer"},{"issue":"10","key":"10.1016\/j.jphs.2025.12.004_bib3","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.ajpath.2017.03.016","article-title":"The spectrum of triple-negative breast disease: high- and low-grade lesions","volume":"187","author":"Geyer","year":"2017","journal-title":"Am J Pathol"},{"issue":"11","key":"10.1016\/j.jphs.2025.12.004_bib4","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2","volume":"344","author":"Slamon","year":"2001","journal-title":"N Engl J Med"},{"issue":"9793","key":"10.1016\/j.jphs.2025.12.004_bib5","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(11)60993-8","article-title":"Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials","volume":"378","author":"Davies","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jphs.2025.12.004_bib6","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1038\/s41467-020-18570-x","article-title":"PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade","volume":"11","author":"Peng","year":"2020","journal-title":"Nat Commun"},{"issue":"7637","key":"10.1016\/j.jphs.2025.12.004_bib7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.jphs.2025.12.004_bib8","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for early triple-negative breast cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jphs.2025.12.004_bib9","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1034\/j.1398-9995.1999.00099.x","article-title":"Biologic functions of the IFN-\u03b3 receptors","volume":"54","author":"Tau","year":"1999","journal-title":"Allergy"},{"issue":"7","key":"10.1016\/j.jphs.2025.12.004_bib10","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1158\/1078-0432.CCR-21-3226","article-title":"IFN\u03b3 signaling in natural and therapy-induced antitumor responses","volume":"28","author":"Mart\u00ednez-Sabadell","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.jphs.2025.12.004_bib11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40364-020-00228-x","article-title":"Roles of IFN-\u03b3 in tumor progression and regression: a review","volume":"8","author":"Jorgovanovic","year":"2020","journal-title":"Biomark Res"},{"issue":"6","key":"10.1016\/j.jphs.2025.12.004_bib12","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","article-title":"Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression","volume":"19","author":"Garcia-Diaz","year":"2017","journal-title":"Cell Rep"},{"issue":"5547","key":"10.1016\/j.jphs.2025.12.004_bib13","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/260170a0","article-title":"DNA related to the transforming gene(s) of Avian sarcoma viruses is present in normal avian DNA","volume":"260","author":"Stehelin","year":"1976","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jphs.2025.12.004_bib14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ccr.2004.09.001","article-title":"c-Src and cooperating partners in human cancer","volume":"6","author":"Ishizawar","year":"2004","journal-title":"Cancer Cell"},{"issue":"18","key":"10.1016\/j.jphs.2025.12.004_bib15","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.1158\/1078-0432.CCR-11-1071","article-title":"Phase II trial of dasatinib in patients with metastatic breast cancer using real-time pharmacodynamic tissue biomarkers of src inhibition to escalate dosing","volume":"17","author":"Herold","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.jphs.2025.12.004_bib16","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1111\/cas.16243","article-title":"Alternative magnetic field exposure suppresses tumor growth via metabolic reprogramming","volume":"115","author":"Akimoto","year":"2024","journal-title":"Cancer Sci"},{"issue":"11","key":"10.1016\/j.jphs.2025.12.004_bib17","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1111\/cas.13781","article-title":"Alternating magnetic field enhances cytotoxicity of compound C","volume":"109","author":"Akimoto","year":"2018","journal-title":"Cancer Sci"},{"issue":"1","key":"10.1016\/j.jphs.2025.12.004_bib18","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s42003-024-06231-4","article-title":"EP4-induced mitochondrial localization and cell migration mediated by CALML6 in human oral squamous cell carcinoma","volume":"7","author":"Ishikawa","year":"2024","journal-title":"Commun Biol"},{"issue":"1","key":"10.1016\/j.jphs.2025.12.004_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12576-024-00928-1","article-title":"Cytotoxic effects of the cigarette smoke extract of heated tobacco products on human oral squamous cell carcinoma: the role of reactive oxygen species and CaMKK2","volume":"74","author":"Kagemichi","year":"2024","journal-title":"J Physiol Sci"},{"issue":"12","key":"10.1016\/j.jphs.2025.12.004_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0278613","article-title":"Store-operated calcium entry via ORAI1 regulates doxorubicin-induced apoptosis and prevents cardiotoxicity in cardiac fibroblasts","volume":"17","author":"Nemoto","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jphs.2025.12.004_bib21","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1038\/s41598-018-24749-6","article-title":"Acute hyperthermia inhibits TGF-\u03b21-induced cardiac fibroblast activation via suppression of akt signaling","volume":"8","author":"Narikawa","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jphs.2025.12.004_bib22","article-title":"FAK-dependent reprogramming of IFN-\u03b3 signaling through PYK2 Co-Inhibition sensitizes melanoma to immune checkpoint blockade","author":"Mizuno","year":"2025","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.jphs.2025.12.004_bib23","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/cas.13851","article-title":"Simultaneous hyperthermia-chemotherapy effect by arterial injection of Fe(Salen) for femur tumor","volume":"110","author":"Umemura","year":"2019","journal-title":"Cancer Sci"},{"issue":"1","key":"10.1016\/j.jphs.2025.12.004_bib24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/cas.14247","article-title":"Prostaglandin E(2) receptor EP4 regulates cell migration through Orai1","volume":"111","author":"Osawa","year":"2020","journal-title":"Cancer Sci"},{"issue":"4","key":"10.1016\/j.jphs.2025.12.004_bib25","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1084\/jem.20160801","article-title":"PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity","volume":"214","author":"Juneja","year":"2017","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.jphs.2025.12.004_bib26","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/s12935-021-02081-w","article-title":"Relationship between PD-L1 expression, CD8+ T-cell infiltration and prognosis in intrahepatic cholangiocarcinoma patients","volume":"21","author":"Deng","year":"2021","journal-title":"Cancer Cell Int"},{"issue":"7","key":"10.1016\/j.jphs.2025.12.004_bib27","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/bjc.2014.416","article-title":"PD-1+ CD8+ T cells are exhausted in tumours and functional in draining lymph nodes of colorectal cancer patients","volume":"111","author":"Wu","year":"2014","journal-title":"Br J Cancer"},{"issue":"5164","key":"10.1016\/j.jphs.2025.12.004_bib28","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1126\/science.8197455","article-title":"Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins","volume":"264","author":"Darnell","year":"1994","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jphs.2025.12.004_bib29","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13046-019-1161-8","article-title":"Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK\/STAT3\/PD-L1 pathway","volume":"38","author":"Shen","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"issue":"13","key":"10.1016\/j.jphs.2025.12.004_bib30","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.7150\/jca.77619","article-title":"Clinical implications of the interaction between PD-1\/PD-L1 and PI3K\/AKT\/mTOR pathway in progression and treatment of non-small cell lung cancer","volume":"13","author":"Quan","year":"2022","journal-title":"J Cancer"},{"issue":"13","key":"10.1016\/j.jphs.2025.12.004_bib31","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1001\/jama.2024.3056","article-title":"Tumor-infiltrating lymphocytes in triple-negative breast cancer","volume":"331","author":"Leon-Ferre","year":"2024","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.jphs.2025.12.004_bib32","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.3390\/cancers13092207","article-title":"TET2 inhibits PD-L1 gene expression in breast cancer cells through histone deacetylation","volume":"13","author":"Shen","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.jphs.2025.12.004_bib33","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1158\/2326-6066.CIR-15-0210","article-title":"PD-1 blockade expands intratumoral memory T cells","volume":"4","author":"Ribas","year":"2016","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"10.1016\/j.jphs.2025.12.004_bib34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbrc.2018.09.005","article-title":"ER\u03b1 is a negative regulator of PD-L1 gene transcription in breast cancer","volume":"505","author":"Liu","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jphs.2025.12.004_bib35","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1750925","article-title":"PD-L1 expression in TNBC: a predictive biomarker of response to neoadjuvant chemotherapy?","volume":"2017","author":"Cerbelli","year":"2017","journal-title":"BioMed Res Int"},{"issue":"1","key":"10.1016\/j.jphs.2025.12.004_bib36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbrc.2018.09.005","article-title":"ER\u03b1 is a negative regulator of PD-L1 gene transcription in breast cancer","volume":"505","author":"Liu","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"10.1016\/j.jphs.2025.12.004_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092207","article-title":"TET2 inhibits PD-L1 gene expression in breast cancer cells through histone deacetylation","volume":"13","author":"Shen","year":"2021","journal-title":"Cancers (Basel)"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S134786132500115X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S134786132500115X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T14:02:30Z","timestamp":1778594550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S134786132500115X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S134786132500115X"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2025.12.004","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Src-dependent modulation of IFN\u03b3-induced PD-L1 expression in human breast cancer cell lines","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2025.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}